EUCTR2018-000045-40-BEActive, not recruitingPhase 1
The effects of nitrous oxide on human vision
niversitair ziekenhuis Brussel0 sites20 target enrollmentStarted: January 12, 2018Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •- Subjects between 18 and 25 years old
- •- Men and women in good health (ASA I).
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •- Younger than 18 years or older than 25 years
- •- Sick people or people having a cold (risk for the eardrum)
- •- volunteers with lung disorders (because of the inhalation of the gas)
- •- No pregnant subjects.
- •- At least 24 h before the experiment, volunteers should be free of party drugs or other medication.
Investigators
Similar Trials
Completed
Not Applicable
The effect of nitrous oxide on the ocular pressure under remifentanil and sevoflurane anesthesiapatients scheduled for elective abdominal surgeryJPRN-UMIN000020241Akita University Graduate School of Medicine, Department of Anesthesiology and Intensive Care Medicine25
Completed
Phase 2
Pupillary Response to Nitrous Oxide Administration in Cataract SurgeryCataract.Senile incipient cataractIRCT2016071319470N34Shiraz University of Medical Sciences40
Active, not recruiting
Not Applicable
The Effects of Nitric Oxide for Inhalation on the Development of Chronic Lung Disease in Pre-term Infants.EUCTR2004-002312-29-DEINO Therapeutics800
Active, not recruiting
Phase 1
The Effects of Nitric Oxide for Inhalation on the development of chronic lung disease in pre-term infants. - INOT-27Prevention of chronic lung disease in pre-term infants ( gestational age < 29 weeks) with respiratory distress.MedDRA version: 7.0 Level: LLT Classification code 10054933EUCTR2004-002312-29-GBINO Therapeutics800
Active, not recruiting
Phase 1
The Effects of Nitric Oxide for Inhalation on the development of chronic lung disease in pre-term infants. - INOT-27Prevention of chronic lung disease in pre-term infants ( gestational age < 29 weeks) with respiratory distress.MedDRA version: 7.0Level: LLTClassification code 10054933EUCTR2004-002312-29-FIINO Therapeutics800